Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea
· Delayed Price · Currency is KRW 6,110.00
-260.00 (-4.08%)
At close: Mar 9, 2026
Seoulin Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 53,932 | 61,462 | 78,767 | 97,546 | 174,747 | 107,487 | Upgrade
|
| Market Cap Growth | -7.08% | -21.97% | -19.25% | -44.18% | 62.58% | 56.83% | Upgrade
|
| Enterprise Value | 34,176 | 39,202 | 46,863 | 48,995 | 136,075 | 93,693 | Upgrade
|
| Last Close Price | 6110.00 | 6845.95 | 8533.50 | 10440.22 | 18480.13 | 11303.23 | Upgrade
|
| PE Ratio | 27.46 | 21.09 | - | 9.60 | 11.21 | 21.97 | Upgrade
|
| PS Ratio | 0.70 | 0.82 | 0.88 | 0.93 | 2.17 | 1.65 | Upgrade
|
| PB Ratio | 0.62 | 0.71 | 0.92 | 1.10 | 2.28 | 1.75 | Upgrade
|
| P/TBV Ratio | 0.64 | 0.74 | 0.96 | 1.17 | 2.36 | 1.82 | Upgrade
|
| P/FCF Ratio | 91.65 | - | - | - | 21.89 | 32.74 | Upgrade
|
| P/OCF Ratio | 74.66 | - | 84.64 | - | 19.60 | 29.17 | Upgrade
|
| EV/Sales Ratio | 0.45 | 0.52 | 0.52 | 0.47 | 1.69 | 1.44 | Upgrade
|
| EV/EBITDA Ratio | 21.58 | 16.92 | 12.39 | 4.80 | 14.51 | 14.52 | Upgrade
|
| EV/EBIT Ratio | 93.89 | 41.15 | 18.79 | 5.33 | 18.26 | 20.96 | Upgrade
|
| EV/FCF Ratio | 58.08 | - | - | - | 17.04 | 28.54 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.04 | 0.08 | 0.20 | 0.21 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 5.92 | 1.59 | 1.78 | 1.74 | 1.68 | 0.12 | Upgrade
|
| Debt / FCF Ratio | 15.82 | - | - | - | 1.97 | 0.23 | Upgrade
|
| Net Debt / Equity Ratio | -0.25 | -0.23 | -0.34 | -0.42 | -0.78 | -0.31 | Upgrade
|
| Net Debt / EBITDA Ratio | -13.76 | -8.56 | -7.59 | -3.67 | -6.35 | -2.96 | Upgrade
|
| Net Debt / FCF Ratio | -36.78 | 4.26 | 1920.12 | 7.78 | -7.46 | -5.82 | Upgrade
|
| Asset Turnover | 0.73 | 0.70 | 0.72 | 0.77 | 0.75 | 0.82 | Upgrade
|
| Inventory Turnover | 2.59 | 2.35 | 3.57 | 5.15 | 4.63 | 4.09 | Upgrade
|
| Quick Ratio | 1.46 | 2.30 | 1.77 | 1.35 | 1.44 | 2.13 | Upgrade
|
| Current Ratio | 2.57 | 4.39 | 2.60 | 1.88 | 1.77 | 3.06 | Upgrade
|
| Return on Equity (ROE) | 3.12% | 3.65% | -2.67% | 12.78% | 23.03% | 7.83% | Upgrade
|
| Return on Assets (ROA) | 0.21% | 0.55% | 1.25% | 4.23% | 4.34% | 3.52% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.53% | 1.36% | 4.63% | 20.31% | 19.66% | 9.08% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.40% | 1.10% | 2.90% | 10.30% | 9.70% | 6.90% | Upgrade
|
| Earnings Yield | 3.93% | 4.74% | -0.15% | 10.41% | 8.92% | 4.55% | Upgrade
|
| FCF Yield | 1.09% | -7.58% | -0.02% | -4.94% | 4.57% | 3.05% | Upgrade
|
| Dividend Yield | 1.50% | 1.40% | - | - | - | - | Upgrade
|
| Payout Ratio | 39.78% | 28.70% | - | 7.86% | 4.93% | 14.74% | Upgrade
|
| Buyback Yield / Dilution | -4.78% | 0.50% | 19.46% | -23.72% | 0.07% | 1.26% | Upgrade
|
| Total Shareholder Return | -3.28% | 1.89% | 19.46% | -23.72% | 0.07% | 1.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.